News
Digital transformation is at the heart of many biopharmaceutical companies’ strategies for ongoing success. However, the definition of digital transformation and what it consists of differ within the ...
Viral contamination has long been a concern in biomanufacturing, especially with the increasing complexity of biologic therapies. Effective viral clearance (VC) is critical to ensure the safety of ...
Even small and early-stage companies can find ways to align knowledge management practices with quality management systems ...
Cell and gene therapies have reached clinical and commercial success as evidenced by the steady number of first approvals over the past four years. Drug developers face mounting challenges linked to ...
Explore the latest news and expert commentary on Cell Culture Media, brought to you by the editors of BioProcess International ...
Explore the latest news and expert commentary on Upstream & Downstream Processing, brought to you by the editors of BioProcess International ...
BIOPROCESSING MASTERED: Unlock commercial success for mAbs, biologics, and ATMPs. From molecule to market, discover cutting-edge strategies to maximize efficiency, drive innovation, and ensure ...
This roundtable took place on Tuesday, 5 June 2018, in the BioProcess Theater at the BIO International Convention in Boston, MA. (Left to Right) Moderator: Patricia Seymour, senior consultant at ...
The steps involved in manufacturing pharmaceutical products require rigorous processes to ensure the safety of patients. One important such process is cleaning validation — a critical element in ...
Isolere Bio is on a mission to transform biomanufacturing and tackle the traditional limitations in downstream processing with its novel IsoTag reagents. This first-of-its-kind technology is based on ...
BIOPROCESSING MASTERED: Unlock commercial success for mAbs, biologics, and ATMPs. From molecule to market, discover cutting-edge strategies to maximize efficiency, drive innovation, and ensure ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results